Scleroderma is classified as a rare, autoimmune, collagen-vascular disease of unknown etiology that can be difficult to diagnose and treat. Its onset can be insidious or rapid; the symptoms range ...

This disease can manifest in various ... The exact cause of scleroderma remains unknown, but it is recognized as having an autoimmune basis, with the most likely reason being a genetic defect.

Scleroderma is a rare disease in which a person's immune system begins to destroy normal, healthy tissues. (This is called an autoimmune disease.) As a result, connective tissue of the skin, lungs, ...

Sjögren's syndrome and scleroderma. The capacity to develop an autoimmune reaction may represent a feature common to patients with Hashimoto's thyroiditis and certain of the collagen diseases ...

After first generating excitement in late 2022, this year was a bonanza for news about chimeric antigen receptor T-cell therapies for autoimmune rheumatic diseases. WASHINGTON — A phase 1/2 ...

Currently, clinicians struggle to diagnose autoimmune disorders, in part because distinct conditions ... For example, a patient with scleroderma may have localized scleroderma, diffuse scleroderma, or ...

Starting later this year, Ouro intends to start a phase 1 clinical trial of its own, eyeing the development of the drug for immune diseases like systemic lupus erythematosus, scleroderma ...

A NEW Swedish study has found that menopausal hormone therapy (MHT) may be associated with an increased risk of developing ...

Scleroderma is an autoimmune connective-tissue disease whose hallmark is excessive collagen deposited around capillaries and in affected tissues, such as the skin, lungs, kidneys, and esophagus.